Gabriele Simontacchi
University of Florence, Azienda Ospedaliero-Universitaria Careggi
Papers
4
Total Citations
110
H-Index
4
About
Dr. Gabriele Simontacchi is a leading radiation oncologist whose research centers on stereotactic body radiotherapy (SBRT) and robotic radiosurgery, particularly for challenging and recurrent cancers. His major contributions include pioneering the use of robotic stereotactic retreatment for biochemical control in previously irradiated patients with recurrent prostate cancer—a study that has garnered 50 citations and reshaped salvage therapy options. He also led the phase II ROCK trial (NCT03520894), demonstrating the efficacy of preoperative robotic radiosurgery for early breast cancer, achieving 29 citations and advancing the paradigm of partial breast irradiation. Additionally, his work on CyberKnife-based SBRT for cardiac malignancies (23 citations) has expanded the role of high-dose, focused radiation for tumors once considered untreatable by conventional radiotherapy. Beyond clinical studies, Dr. Simontacchi contributed to quality assurance with the ADAM phantom (8 citations), a tool for testing 4D imaging and dose delivery in moving targets. His research bridges technical innovation and clinical application, offering new hope for patients with complex or recurrent disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Stereotactic Body Radiotherapy with Cyberknife for Cardiac Malignancies23 citations · 2015
- 4ADAM phantom to test 4D medical imaging and dose delivery devices8 citations · 2019